WHO prequalifies diagnostic test to support safer administration of P. vivax malaria treatments
On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse…
Lire la suite / Read more
